Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP614979.RAaZwUHYE-F9jZdwMQT5I_wViteET2CEKF_ZQr6IBGSdQ130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP614979.RAaZwUHYE-F9jZdwMQT5I_wViteET2CEKF_ZQr6IBGSdQ130_assertion type Assertion NP614979.RAaZwUHYE-F9jZdwMQT5I_wViteET2CEKF_ZQr6IBGSdQ130_head.
- NP614979.RAaZwUHYE-F9jZdwMQT5I_wViteET2CEKF_ZQr6IBGSdQ130_assertion description "[Treatment with carbamazepine and gabapentin of a patient with primary erythermalgia (erythromelalgia) identified to have a mutation in the SCN9A gene, encoding a voltage-gated sodium channel.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP614979.RAaZwUHYE-F9jZdwMQT5I_wViteET2CEKF_ZQr6IBGSdQ130_provenance.
- NP614979.RAaZwUHYE-F9jZdwMQT5I_wViteET2CEKF_ZQr6IBGSdQ130_assertion evidence source_evidence_literature NP614979.RAaZwUHYE-F9jZdwMQT5I_wViteET2CEKF_ZQr6IBGSdQ130_provenance.
- NP614979.RAaZwUHYE-F9jZdwMQT5I_wViteET2CEKF_ZQr6IBGSdQ130_assertion SIO_000772 19549232 NP614979.RAaZwUHYE-F9jZdwMQT5I_wViteET2CEKF_ZQr6IBGSdQ130_provenance.
- NP614979.RAaZwUHYE-F9jZdwMQT5I_wViteET2CEKF_ZQr6IBGSdQ130_assertion wasDerivedFrom befree-20140225 NP614979.RAaZwUHYE-F9jZdwMQT5I_wViteET2CEKF_ZQr6IBGSdQ130_provenance.
- NP614979.RAaZwUHYE-F9jZdwMQT5I_wViteET2CEKF_ZQr6IBGSdQ130_assertion wasGeneratedBy ECO_0000203 NP614979.RAaZwUHYE-F9jZdwMQT5I_wViteET2CEKF_ZQr6IBGSdQ130_provenance.